Novartis Investigative Site

Slagelse DK-4200

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Relapsing Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early